A Phase 1, First in Human (FIH) study of autologous macrophages containing an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors.

CT-0508 - CARISMA Therap

Neupogen (filgrastim) - Kyowa Kirin, Amgen

Keytruda (pembrolizumab) - Merck (MSD)

https://jitc.bmj.com/content/10/Suppl_2/A663

Kim Reiss 1; Naoto Ueno 2; Yuan Yuan 3; Melissa Johnson 4; E Claire Dees 5; Joseph Chao 3; Mathew Angelos 6; Ramona Swaby 7; Daniel Cushing 7; Amy Ronczka 7; Thomas Condamine 7; Debora Barton 7; Michael Klichinsky 7; Yara Abdou 5

Oct 6, 2022